Weekly Injected Drug Could Boost Outcomes for Patients With Type 2 Diabetes
TUESDAY, June 29, 2021 -- People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Heart | Heart Attack | Stroke | Urology & Nephrology